Intellia Therapeutics to Participate at June Healthcare Investor Conferences
30 Mai 2019 - 10:30PM
Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing
company focused on developing curative therapeutics using
CRISPR/Cas9 technology both in vivo and ex vivo, will participate
in the following upcoming healthcare conferences in June:
Tuesday, June 4, 2019Jefferies
Healthcare ConferenceLocation: New York, NY
Tuesday, June 18, 2019Raymond James
Life Sciences and MedTech ConferenceLocation: New York,
NYTime: 1:15 p.m. ET
A live webcast of Intellia’s presentation at the Raymond James
Conference will be accessible through the Events and Presentations
page of the Investor Relations section of the company’s website at
www.intelliatx.com. To access the webcast, please log on to the
Intellia website approximately 15 minutes prior to the start time
to ensure adequate time for any software downloads that may be
required. A replay of the webcast will be available on Intellia’s
website for approximately 14 days following the conference.
About Intellia Therapeutics
Intellia Therapeutics is a leading genome editing company
focused on developing proprietary, curative therapeutics using the
CRISPR/Cas9 system. Intellia believes the CRISPR/Cas9 technology
has the potential to transform medicine by permanently editing
disease-associated genes in the human body with a single treatment
course, and through improved cell therapies that can treat cancer
and immunological diseases, or can replace patients’ diseased
cells. The combination of deep scientific, technical and clinical
development experience, along with its leading intellectual
property portfolio, puts Intellia in a unique position to unlock
broad therapeutic applications of the CRISPR/Cas9 technology and
create a new class of therapeutic products. Learn more about
Intellia Therapeutics and CRISPR/Cas9 at intelliatx.com and follow
us on Twitter @intelliatweets.
Investor
Contact:
Lina Li Senior Manager, Investor Relations +1 857-706-1612
lina.li@intelliatx.com
Media Contact:Jennifer Mound Smoter Senior Vice
President, External Affairs & Communications +1 857-706-1071
jenn.smoter@intelliatx.com
Intellia Therapeutics (NASDAQ:NTLA)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
Intellia Therapeutics (NASDAQ:NTLA)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024